Ultra long acting basal insulin - Gan & Lee Pharmaceuticals
Alternative Names: GZR-33Latest Information Update: 30 Mar 2023
At a glance
- Originator Gan&Lee Pharmaceuticals
- Class Antihyperglycaemics; Insulins; Pancreatic hormones; Peptides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Diabetes mellitus